REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ISU Abxis Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: ISU Abxis Co.,Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

ISU Abxis Co., Ltd is a biotechnology company that develops engineered antibody-based therapeutics aimed at treating cancer and rare diseases. The company claims to address unmet medical needs in the fields of oncology and rare diseases through its antibody development technology.

Headquarters
5F C-Dong 22 No.712 Daewangpangyo-Road, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;

Contact Details: Purchase the ISU Abxis Co.,Ltd. report to view the information.

Website: http://www.abxis.com

Basic Information
Total Employees:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Registered Capital:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Incorporation Date:
March 29, 2001
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
3.28%
Purchase this report to view the information.
0.16%
Purchase this report to view the information.
0.05%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Subsidiaries
(주)이수앱지스
Company Performance
Financial values in the chart are available after ISU Abxis Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.96%▲
Total operating revenue
4.82%▲
Operating Profit/Loss (EBIT)
-1571.54%▼
EBITDA
192.89%▲
Net Profit/Loss for the Period
-190.14%▼
Total Assets
-5.9%▼
Total Equity
22.06%▲
Operating Profit Margin (ROS)
-23.18%▼
Net Profit Margin
-21.28%▼
Return on Equity (ROE)
-10.47%▼
Debt/Equity
-27.48%▼
Quick Ratio
-0.16%▼
Cash Ratio
0.11%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo